Nurix Therapeutics reports Q3 FY2026 financial results for quarter ended February 28

Filed April 8, 2026 · Period ending April 8, 2026 · ~1 min read

Key Changes

• medium

  Company issued press release announcing financial results for the fiscal quarter ended February 28, 2026. Actual financial figures are contained in the attached press release, not in the 8-K body itself.

  Item 7.01 view on EDGAR →
• low

  This is a standard quarterly earnings announcement filing. The 8-K serves as a procedural wrapper for the press release (Exhibit 99.1) containing the actual financial data.

  8-K: Earnings verify on EDGAR →